Tran KB, Kolekar S, Jabed A, Jaynes P, et al. Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK. BMC Cancer 2021;21:136.
PMID: 33549048